Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for treating cerebral haemorrhage sequelae

A technology for sequelae and cerebral congestion, which is applied in the field of traditional Chinese medicine for the treatment of sequelae of cerebral congestion, can solve the problems of high price, acute adverse reactions and obvious side effects, and the inability of patients to recover their self-care ability.

Inactive Publication Date: 2014-10-01
王伟
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, anticoagulants and thrombolytics are the main drugs for clinical treatment. The adverse reactions are obvious, and the side effects are obvious. They are easy to degrade the plasma proteins in the blood. They are expensive and basically cannot restore the patient's self-care ability.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Blue cloth 10g, Ophiopogon japonicus 5g, Platycodon grandiflorum 8g, the above medicines are ground into powder form, this is a sub-dose (one-time dose), and the powder medicines are made into capsules, tablets or other oral administration methods according to the conventional methods in this field. Dosage forms such as liquids.

[0014] Taking cycle: Take it at dinner time, once a day, the interval between the first drug and the second drug is 3 days, and the rest is 5 days, until the recovery, generally about 5 drugs can be cured, according to the patient's condition depends.

[0015] Taboo: sour cold tea, hair food (beef and mutton, etc.).

Embodiment 2

[0017] 20g of blue cloth, 10g of Ophiopogon japonicus, 15g of Platycodon grandiflorum, the above medicines are ground into powder form, this is a sub-dose (one-time dose), and the powder medicines are made into capsules, tablets or other oral administration methods according to the conventional methods in this field. Dosage forms such as liquids.

[0018] Taking cycle: Take it at dinner time, once a day, the interval between the first drug and the second drug is 3 days, and the rest is 5 days, until the recovery, generally about 5 drugs can be cured, according to the patient's condition depends.

[0019] Taboo: sour cold tea, hair food (beef and mutton, etc.).

Embodiment 3

[0021] 40g of blue cloth, 20g of Ophiopogon japonicus, 30g of Platycodon grandiflorum, the above medicines are ground into powder form, this is a sub-dose (one-time dose), and the powder medicines are made into capsules, tablets or other oral administration methods according to the conventional methods in this field. Dosage forms such as liquids.

[0022] Taking cycle: Take it at dinner time, once a day, the interval between the first drug and the second drug is 3 days, and the rest is 5 days, until the recovery, generally about 5 drugs can be cured, according to the patient's condition depends.

[0023] Taboo: sour cold tea, hair food (beef and mutton, etc.).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug for treating cerebral haemorrhage sequelae, which is characterized by being prepared from the following raw materials in parts by weight: 10-40 parts of aleppo avens, 5-20 parts of ophiopogon root, and 8-30 parts of bitter platycodon grandiflorum.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicine for treating sequelae of cerebral congestion. Background technique [0002] Cerebral hemorrhage refers to non-traumatic intraparenchymal hemorrhage, which often forms intracerebral hematomas of various sizes, and sometimes penetrates the brain parenchyma to form secondary intraventricular and (or) subarachnoid hemorrhage. It mainly occurs in patients with hypertension and cerebral arteriosclerosis. The main clinical manifestation is stroke attack, headache, vomiting, disturbance of consciousness, hemiplegia and (or) sensory disturbance, etc. It is also called hemorrhagic stroke. A common disease with a high disability rate. [0003] According to the statistics of several major cities in China, the incidence of cerebral hemorrhage accounts for 20%-48% of stroke, and the mortality rate is about 50%. Cerebral hemorrhage belongs to the cat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8968A61P9/10A61P25/02
Inventor 王伟
Owner 王伟
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com